Skip to Content
  • Review
  • Open Access

21 November 2022

19 Pages

Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature

,
,
,
and
1
Department of Medicine III, Technische Universität Dresden Medical Center, 01307 Dresden, Germany
2
Center for Healthy Aging, Technische Universität Dresden Medical Center, 01307 Dresden, Germany
3
Department of Endocrinology, 424 General Military Hospital, 56429 Thessaloniki, Greece
*
Author to whom correspondence should be addressed.
This article belongs to the Section Orthopedics

Abstract

Irisin is a hormone-like myokine produced by the skeletal muscle in response to exercise. Upon its release into the circulation, it is involved in the browning process and thermogenesis, but recent evidence indicates that this myokine could also regulate the functions of osteoblasts, osteoclasts, and osteocytes. Most human studies have reported that serum irisin levels decrease with age and in conditions involving bone diseases, including both primary and secondary osteoporosis. However, it should be emphasized that recent findings have called into question the importance of circulating irisin, as well as the validity and reproducibility of current methods of irisin measurement. In this review, we summarize data pertaining to the role of irisin in the bone homeostasis of healthy children and adults, as well as in the context of primary and secondary osteoporosis. Additional research is required to address methodological issues, and functional studies are required to clarify whether muscle and bone damage per se affect circulating levels of irisin or whether the modulation of this myokine is caused by the inherent mechanisms of underlying diseases, such as genetic or inflammatory causes. These investigations would shed further light on the effects of irisin on bone homeostasis and bone disease.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.